IL2114

N/A

Report date: 2024/08/21 14:44:22

Base Information

Drug NameIL2114
Drug Alias NameIL2114IL-2114
ClassificationOther
Mechanisms of ActionABL proto-oncogene 1 inhibitors
TargetsABL proto-oncogene 1
Therapy Area/IndicationsAmyotrophic Lateral SclerosisParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesiLeadBMS Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiLeadBMS Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A